Feng Gao

Dr. Feng Gao


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2022 in Journal of Advanced Research
Verified
Journal Article
Open access
CDChaoran Dong
Chaoran Dong
YYYanan Yang
Yanan Yang
YWYinghong Wang
Yinghong Wang
XHXiaomin Hu
Xiaomin Hu
QWQingchun Wang
Qingchun Wang
HZHaibo Zhu
Haibo Zhu
Acute myocardial infarction (AMI) accounts for the majority of deaths caused by coronary artery disease (CAD). Early warning of AMI, especially for patients with stable coronary artery disease (sCAD), is urgently needed. Our previous study showed that alterations in the gut microbiota were correlated with CAD severity. Herein, we tried to discover accurate and convenient biomarkers for AMI by combination of gut microbiota and fecal/blood/urinary metabolomics. We recruited 190 volunteers including 93 sCAD patients, 49 AMI patients, and 48 subjects with normal coronary artery (NCA), and measured their blood biochemical parameters, 16S rRNA-based gut microbiota and NMR-based fecal/blood/urinary metabolites. We further selected 20 subjects from each group and analyzed their gut microbiota by whole-metagenome shotgun sequencing. Multi-omic analyses revealed that AMI patients exhibited specific changes in gut microbiota and serum/urinary/fecal metabolites as compared to subjects with sCAD or NCA. Fourteen bacterial genera and 30 metabolites (11 in feces, 10 in blood, 9 in urine) were closely related to AMI phenotypes and could accurately distinguish AMI patients from sCAD patients. Some species belonging to Alistipes, Streptococcus, Ruminococcus, Lactobacillus and Faecalibacterium were effective to distinguish AMI from sCAD and their predictive ability was confirmed in an independent cohort of CAD patients. We further selected nine indicators including 4 bacterial genera, 3 fecal and 2 urinary metabolites as a noninvasive biomarker set which can distinguish AMI from sCAD with an AUC of 0.932. Combination of gut microbiota and fecal/urinary metabolites provided a set of potential useful and noninvasive predictive biomarker for AMI from sCAD.

1 February 2023 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
YHYiwei Hao
Yiwei Hao
YYYan Yang
Yan Yang
FCFuhou Chang
Fuhou Chang
MWMinjie Wang
Minjie Wang
FGFeng Gao
Feng Gao
LFLei Fan
Lei Fan

10 November 2023 in Medicine
Verified
Journal Article
Open access
YQYuan-Yuan Mm Qin
Yuan-Yuan Mm Qin
YYYan Yang
Yan Yang
YRYan-Hui Mm Ren
Yan-Hui Mm Ren
FGFeng Gao
Feng Gao
MWMin-Jie Wang
Min-Jie Wang
LFLei Fan
Lei Fan
The mitogen-activated protein kinases family of genes plays a crucial role in a wide range of inflammatory responses in the human body. The MAPK family of genes includes ERK, ERK5, JNK, P-38 mitogen-activated protein kinases. However, the correlation between MAPK family gene expression and pan-cancer prognosis, as well as the tumor microenvironment, has not been extensively studied. This study integrated multiple bioinformatics analysis methods to assess the expression and prognostic value of MAPK family genes, as well as their relationship with tumor microenvironment in patients with pan-cancer. The results showed that ERK, JNK, and P-38 MAPK expression were found to be significantly upregulated in rectum adenocarcinoma (READ), colon adenocarcinoma/rectum adenocarcinoma esophageal carcinoma (COADREAD), and kidney renal clear cell carcinoma (KIRC), and significantly downregulated in acute myeloid leukemia. And the results revealed good prognostic results for ERK, JNK, and P-38 MAPK in READ, COADREAD, and KIRC. We observed significant positive correlation between MAPK family gene expression and immune scores especially dendritic cells in READ, COADREAD, and KIRC. And we observed that the expression levels of MAPK family genes were significantly correlated with the expression of immune-related genes, such as CXCL1, CXCL2, CXCL8, CXCR1, CXCR2, CTLA-4, CD80, CD86, and CD28, suggesting their important role in regulating immune infiltrates and tumor progression. Therefore, our study suggested that MAPK family gene plays an important role in regulating immune infiltrates and tumor progression.

21 March 2025 in Medicine
Verified
Journal Article
Open access
QGQian Gao
Qian Gao
YCYan Cui
Yan Cui
FGFeng Gao
Feng Gao
YYYan Yang
Yan Yang
WHWeizhong Huangfu
Weizhong Huangfu
JWJie Min Wang
Jie Min Wang
PDGFRB is a type III tyrosine-protein kinase that is abnormally expressed in various cancers and can serve as a biomarker for cancer prognosis, as studies have demonstrated. However, a pan-cancer analysis of PDGFRB has not yet been carried out. The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases were utilized to analyze PDGFRB expression levels. Differential expression of PDGFRB in standard, tumor, and different clinical stage samples was calculated using R software (version 3.6.4). Immunohistochemical staining for Cholangiocarcinoma (CHOL) and Esophageal carcinoma (ESCA) was conducted on clinical patient samples. High-quality prognostic datasets from TCGA have been published in previous studies. Additionally, the TARGET follow-up data were obtained as supplementary information, excluding models with a follow-up period of less than 30 days. After conducting a rain analysis of PDGFRB, Kaplan–Meier and univariate Cox regression analyses were performed using the R software package. The DNA tumor stemness scores, derived from methylation signatures for each tumor, were obtained from previous studies. Finally, the infiltration of immune cells was analyzed, and the Pearson correlation between PDGFRB and five immune pathway marker genes was assessed. PDGFRB exhibited differential expression across most tumor types in TCGA, indicating a correlation with poor survival outcomes. The expression of PDGFRB influences the regulation of the immune system and is closely associated with immune cell infiltration, immune checkpoints, immune-activating genes, immune suppressor genes, chemokines, and chemokine receptors. PDGFRB is a cancer gene closely associated with prognosis and immunity in cancer patients, and it may serve as an immune checkpoint.